{"transactions":[{"id":1079609,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-29T21:32:38.000Z","date":"2025-07-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":397199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":397199},"source":{"system":"sec-edgar","filing":"0000950170-25-099848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1777513/000095017025099848/ownership.xml","form_type":"4"}},{"id":1079608,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-29T21:32:38.000Z","date":"2025-07-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0000950170-25-099848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777513/000095017025099848/ownership.xml","form_type":"4"}},{"id":1079607,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-29T21:32:38.000Z","date":"2025-07-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":181000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":181000},"source":{"system":"sec-edgar","filing":"0000950170-25-099848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777513/000095017025099848/ownership.xml","form_type":"4"}},{"id":1079606,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-29T21:32:38.000Z","date":"2025-07-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":4630,"price":17.16,"value":79450.8,"ownership":{"direct":true},"balance_after":11146,"source":{"system":"sec-edgar","filing":"0000950170-25-099848","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777513/000095017025099848/ownership.xml","form_type":"4"}},{"id":1079605,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-29T21:32:38.000Z","date":"2025-07-28","kind":"grant","planned":false,"acquired":true,"shares":15776,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. (\"Ikena\")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena."}],"balance_after":15776,"source":{"system":"sec-edgar","filing":"0000950170-25-099848","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777513/000095017025099848/ownership.xml","form_type":"4"}},{"id":1660552,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Head of Corp. Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T17:08:02.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":181000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on January 1, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":181000,"derivative":{"exercise_price":1.36,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":181000},"source":{"system":"sec-edgar","filing":"0000950170-24-010601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777513/000095017024010601/ownership.xml","form_type":"4"}},{"id":2061570,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Head of Corp. Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-05T16:15:17.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":105000,"derivative":{"exercise_price":2.62,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0000899243-23-000986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777513/000089924323000986/doc4.xml","form_type":"4"}},{"id":2290947,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Head of Corp. Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-25T18:54:29.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":397199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on April 25, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":397199,"derivative":{"exercise_price":5.88,"expiration_date":"2032-04-25","underlying":"Common Stock","underlying_shares":397199},"source":{"system":"sec-edgar","filing":"0000899243-22-015586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777513/000089924322015586/doc4.xml","form_type":"4"}},{"id":2431441,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, CFO, and CBO"}}],"security":"Employee Stock Option","published_at":"2022-01-20T22:17:48.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the options vest on 1/18/2023; the remaining 50% vest as follows:  1/3 on 1/18/2024; 1/3 on 1/18/2025; and 1/3 on 1/18/2026."}],"balance_after":600000,"derivative":{"exercise_price":1.34,"expiration_date":"2032-01-17","underlying":"Common Shares","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001567619-22-001379","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761922001379/doc1.xml","form_type":"4"}},{"id":2594068,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, CFO, and CBO"}}],"security":"Performance Stock Option","published_at":"2021-08-23T20:57:37.000Z","date":"2021-08-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on August 19, 2021 and vest upon the earlier of (i) certain performance conditions or (ii) August 19, 2025, subject to Reporting Person's continued employment with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest in connection with licensing and partnering events."}],"balance_after":200000,"derivative":{"exercise_price":2.35,"expiration_date":"2031-08-19","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001567619-21-016232","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921016232/doc1.xml","form_type":"4"}},{"id":2594067,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, CFO, and CBO"}}],"security":"Performance Stock Option","published_at":"2021-08-23T20:57:37.000Z","date":"2021-08-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on August 19, 2021 and vest upon the earlier of (i) certain performance conditions or (ii) August 19, 2025, subject to Reporting Person's continued employment with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest in tranches connected with financing events."}],"balance_after":200000,"derivative":{"exercise_price":2.35,"expiration_date":"2031-08-19","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001567619-21-016232","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921016232/doc1.xml","form_type":"4"}},{"id":2917340,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-06T22:19:01.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":343000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 4, 2021.  One-half of the options vest on January 4, 2022.  The remaining one-half of the options vest as follows:  1/3 on January 4, 2023; 1/3 on January 4, 2024; and 1/3 on January 4, 2025."}],"balance_after":343000,"derivative":{"exercise_price":4.37,"expiration_date":"2031-01-04","underlying":"Common Shares","underlying_shares":343000},"source":{"system":"sec-edgar","filing":"0001567619-21-000640","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921000640/doc1.xml","form_type":"4"}},{"id":3085250,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Common Shares","published_at":"2020-07-10T22:53:21.000Z","date":"2020-07-10","kind":"sale","acquired":false,"shares":62835,"price":6.05,"value":380151.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of 120,000 restricted stock units, previously reported on a Form 4/A filed with Securities and Commission on March 10, 2020."}],"balance_after":116219,"source":{"system":"sec-edgar","filing":"0001567619-20-013185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920013185/doc1.xml","form_type":"4"}},{"id":3093697,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Common Shares","published_at":"2020-07-03T00:08:26.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":20946,"price":6.3398,"value":132793.4508,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of 40,000 restricted stock units, previously reported on a Form 4/A filed with Securities and Commission on May 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":179054,"source":{"system":"sec-edgar","filing":"0001567619-20-012894","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920012894/doc1.xml","form_type":"4"}},{"id":3158619,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Common Shares","published_at":"2020-05-07T21:24:44.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units previously granted with the following original vesting dates:  One-half vesting on September 3, 2019, and one-half vesting on June 3, 2020.  The second half of the grant shall now vest on July 2, 2020."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001567619-20-009232","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920009232/doc1.xml","form_type":"4/A","original_submission_date":"2019-06-05"}},{"id":3158617,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Common Shares","published_at":"2020-05-07T20:38:25.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units previously granted with original vesting date of June 10, 2020, shall now vest on July 10, 2020."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001567619-20-009219","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920009219/doc1.xml","form_type":"4/A","original_submission_date":"2020-03-12"}},{"id":3214408,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Common Shares","published_at":"2020-03-12T20:33:33.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units which shall vest on June 10, 2020."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001567619-20-006192","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920006192/doc1.xml","form_type":"4"}},{"id":3295523,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Employee Option Grant","published_at":"2020-02-04T02:47:20.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the options vest on 1/31/2021; the remaining 50% vest as follows:  1/3 on 1/31/2022; 1/3 on 1/31/2023; and 1/3 on 1/31/2024."}],"balance_after":400000,"derivative":{"exercise_price":6.91,"expiration_date":"2030-01-30","underlying":"Common Shares","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001567619-20-001983","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920001983/doc1.xml","form_type":"4"}},{"id":3501263,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2019-06-05T17:21:23.000Z","date":"2019-06-03","kind":"grant","acquired":false,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One half of the options will vest on 6/3/2020; the remaining one-half will vest as follows: 1/3 on\n6/3/2021; 1/3 on 6/3/2022; and 1/3 on 6/3/2023."}],"balance_after":320000,"derivative":{"exercise_price":2,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001567619-19-012814","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761919012814/doc1.xml","form_type":"4"}},{"id":3501262,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":77093,"kind":"person","name":"Marango Jotin","position":1,"cik":"0001777513","reported_name":"Marango Jotin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Chief Bus. Officer"}}],"security":"Common Shares","published_at":"2019-06-05T17:21:23.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units which shall vest as follows: One-half on 9/3/2019 and one-half on 6/3/2020."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001567619-19-012814","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761919012814/doc1.xml","form_type":"4"}}]}